vs
IRONWOOD PHARMACEUTICALS INC（IRWD）与RE/MAX Holdings, Inc.（RMAX）财务数据对比。点击上方公司名可切换其他公司
RE/MAX Holdings, Inc.的季度营收约是IRONWOOD PHARMACEUTICALS INC的1.5倍（$71.1M vs $47.7M），RE/MAX Holdings, Inc.净利率更高（2.0% vs -4.8%，领先6.8%），RE/MAX Holdings, Inc.同比增速更快（-1.8% vs -47.3%），IRONWOOD PHARMACEUTICALS INC自由现金流更多（$74.6M vs $33.5M），过去两年RE/MAX Holdings, Inc.的营收复合增速更高（-4.7% vs -20.2%）
Ironwood制药公司是一家上市制药企业，其前身为Microbia公司，专注于制药领域相关业务研发与运营，面向市场开发各类创新医药产品，满足未被充分满足的临床医疗需求。
RE/MAX是全球知名的房地产特许经营机构，业务遍布全球一百多个国家和地区，旗下拥有数千家门店，总计超过十万名房产经纪人，在国际房产中介领域拥有极高的品牌知名度与市场影响力。
IRWD vs RMAX — 直观对比
营收规模更大
RMAX
是对方的1.5倍
$47.7M
营收增速更快
RMAX
高出45.5%
-47.3%
净利率更高
RMAX
高出6.8%
-4.8%
自由现金流更多
IRWD
多$41.1M
$33.5M
两年增速更快
RMAX
近两年复合增速
-20.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $47.7M | $71.1M |
| 净利润 | $-2.3M | $1.4M |
| 毛利率 | — | — |
| 营业利润率 | 14.3% | 13.1% |
| 净利率 | -4.8% | 2.0% |
| 营收同比 | -47.3% | -1.8% |
| 净利润同比 | -200.9% | -75.2% |
| 每股收益（稀释后） | $0.01 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IRWDRMAX
| Q4 25 | $47.7M | $71.1M | ||
| Q3 25 | $122.1M | $73.2M | ||
| Q2 25 | $85.2M | $72.8M | ||
| Q1 25 | $41.1M | $74.5M | ||
| Q4 24 | $90.5M | $72.5M | ||
| Q3 24 | $91.6M | $78.5M | ||
| Q2 24 | $94.4M | $78.5M | ||
| Q1 24 | $74.9M | $78.3M |
净利润IRWDRMAX
| Q4 25 | $-2.3M | $1.4M | ||
| Q3 25 | $40.1M | $4.0M | ||
| Q2 25 | $23.6M | $4.7M | ||
| Q1 25 | $-37.4M | $-2.0M | ||
| Q4 24 | $2.3M | $5.8M | ||
| Q3 24 | $3.6M | $966.0K | ||
| Q2 24 | $-860.0K | $3.7M | ||
| Q1 24 | $-4.2M | $-3.4M |
营业利润率IRWDRMAX
| Q4 25 | 14.3% | 13.1% | ||
| Q3 25 | 61.8% | 25.0% | ||
| Q2 25 | 53.2% | 19.3% | ||
| Q1 25 | -70.7% | 7.2% | ||
| Q4 24 | 34.8% | 5.9% | ||
| Q3 24 | 28.0% | 19.4% | ||
| Q2 24 | 26.5% | 20.6% | ||
| Q1 24 | 14.7% | 5.8% |
净利率IRWDRMAX
| Q4 25 | -4.8% | 2.0% | ||
| Q3 25 | 32.8% | 5.4% | ||
| Q2 25 | 27.7% | 6.4% | ||
| Q1 25 | -90.9% | -2.6% | ||
| Q4 24 | 2.5% | 8.0% | ||
| Q3 24 | 4.0% | 1.2% | ||
| Q2 24 | -0.9% | 4.7% | ||
| Q1 24 | -5.6% | -4.3% |
每股收益（稀释后）IRWDRMAX
| Q4 25 | $0.01 | — | ||
| Q3 25 | $0.23 | — | ||
| Q2 25 | $0.14 | — | ||
| Q1 25 | $-0.23 | — | ||
| Q4 24 | $0.03 | — | ||
| Q3 24 | $0.02 | — | ||
| Q2 24 | $-0.01 | — | ||
| Q1 24 | $-0.03 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $215.5M | $118.7M |
| 总债务越低越好 | — | $432.2M |
| 股东权益账面价值 | $-261.8M | $452.4M |
| 总资产 | $396.9M | $582.5M |
| 负债/权益比越低杠杆越低 | — | 0.96× |
8季度趋势，按日历期对齐
现金及短期投资IRWDRMAX
| Q4 25 | $215.5M | $118.7M | ||
| Q3 25 | $140.4M | $107.5M | ||
| Q2 25 | $92.9M | $94.3M | ||
| Q1 25 | $108.5M | $89.1M | ||
| Q4 24 | $88.6M | $96.6M | ||
| Q3 24 | $88.2M | $83.8M | ||
| Q2 24 | $105.5M | $66.1M | ||
| Q1 24 | $121.5M | $82.1M |
总债务IRWDRMAX
| Q4 25 | — | $432.2M | ||
| Q3 25 | $199.5M | $433.3M | ||
| Q2 25 | $199.3M | $434.4M | ||
| Q1 25 | $199.2M | $435.3M | ||
| Q4 24 | $199.0M | $436.2M | ||
| Q3 24 | $198.8M | $437.2M | ||
| Q2 24 | $198.6M | $438.1M | ||
| Q1 24 | $398.3M | $439.0M |
股东权益IRWDRMAX
| Q4 25 | $-261.8M | $452.4M | ||
| Q3 25 | $-264.2M | $448.1M | ||
| Q2 25 | $-308.2M | $442.4M | ||
| Q1 25 | $-334.1M | $433.5M | ||
| Q4 24 | $-301.3M | $429.5M | ||
| Q3 24 | $-311.3M | $423.1M | ||
| Q2 24 | $-321.7M | $418.4M | ||
| Q1 24 | $-330.5M | $412.0M |
总资产IRWDRMAX
| Q4 25 | $396.9M | $582.5M | ||
| Q3 25 | $396.1M | $582.2M | ||
| Q2 25 | $342.9M | $574.8M | ||
| Q1 25 | $327.2M | $571.4M | ||
| Q4 24 | $350.9M | $581.6M | ||
| Q3 24 | $389.5M | $578.6M | ||
| Q2 24 | $395.6M | $571.4M | ||
| Q1 24 | $438.8M | $566.7M |
负债/权益比IRWDRMAX
| Q4 25 | — | 0.96× | ||
| Q3 25 | — | 0.97× | ||
| Q2 25 | — | 0.98× | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | 1.02× | ||
| Q3 24 | — | 1.03× | ||
| Q2 24 | — | 1.05× | ||
| Q1 24 | — | 1.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $74.6M | $40.9M |
| 自由现金流经营现金流 - 资本支出 | $74.6M | $33.5M |
| 自由现金流率自由现金流/营收 | 156.3% | 47.1% |
| 资本支出强度资本支出/营收 | 0.0% | 10.4% |
| 现金转化率经营现金流/净利润 | — | 28.39× |
| 过去12个月自由现金流最近4个季度 | $127.0M | $56.8M |
8季度趋势，按日历期对齐
经营现金流IRWDRMAX
| Q4 25 | $74.6M | $40.9M | ||
| Q3 25 | $47.6M | $17.7M | ||
| Q2 25 | $-15.1M | $4.6M | ||
| Q1 25 | $20.0M | $5.7M | ||
| Q4 24 | $15.2M | $59.7M | ||
| Q3 24 | $9.9M | $17.6M | ||
| Q2 24 | $33.5M | $15.9M | ||
| Q1 24 | $45.0M | $9.4M |
自由现金流IRWDRMAX
| Q4 25 | $74.6M | $33.5M | ||
| Q3 25 | $47.6M | $16.4M | ||
| Q2 25 | $-15.1M | $2.9M | ||
| Q1 25 | $19.9M | $4.0M | ||
| Q4 24 | — | $53.0M | ||
| Q3 24 | $9.9M | $16.3M | ||
| Q2 24 | $33.4M | $14.0M | ||
| Q1 24 | $44.9M | $6.8M |
自由现金流率IRWDRMAX
| Q4 25 | 156.3% | 47.1% | ||
| Q3 25 | 39.0% | 22.4% | ||
| Q2 25 | -17.7% | 4.0% | ||
| Q1 25 | 48.4% | 5.3% | ||
| Q4 24 | — | 73.2% | ||
| Q3 24 | 10.8% | 20.8% | ||
| Q2 24 | 35.4% | 17.8% | ||
| Q1 24 | 60.0% | 8.6% |
资本支出强度IRWDRMAX
| Q4 25 | 0.0% | 10.4% | ||
| Q3 25 | 0.0% | 1.8% | ||
| Q2 25 | 0.0% | 2.2% | ||
| Q1 25 | 0.1% | 2.3% | ||
| Q4 24 | 0.0% | 9.1% | ||
| Q3 24 | 0.0% | 1.7% | ||
| Q2 24 | 0.1% | 2.4% | ||
| Q1 24 | 0.1% | 3.3% |
现金转化率IRWDRMAX
| Q4 25 | — | 28.39× | ||
| Q3 25 | 1.19× | 4.45× | ||
| Q2 25 | -0.64× | 0.97× | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.74× | 10.28× | ||
| Q3 24 | 2.71× | 18.22× | ||
| Q2 24 | — | 4.29× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IRWD
暂无分部数据
RMAX
| Franchising Segment | $50.1M | 70% |
| Broker Fees | $13.9M | 20% |
| Annual Dues | $7.4M | 10% |
